mannitol has been researched along with alx-0600 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, A; Burton, D; Camilleri, M; Carlson, PJ; Edakkanambeth Varayil, J; Hurt, R; Iturrino, J; O'Neill, J; Zinsmeister, AR | 1 |
| Blüthner, E; Büttner, J; Elezkurtaj, S; Greif, S; Jochum, C; Kühl, A; Maasberg, S; Pape, UF; Tacke, F; Ulrich, J | 1 |
1 trial(s) available for mannitol and alx-0600
| Article | Year |
|---|---|
Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Topics: Adult; Aged; Citrulline; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Tract; Glucagon-Like Peptide 2; Humans; Intestinal Absorption; Lactulose; Male; Mannitol; Middle Aged; Parenteral Nutrition, Home; Peptides; Permeability; Pilot Projects; Recombinant Proteins; Short Bowel Syndrome; Treatment Outcome | 2016 |
1 other study(ies) available for mannitol and alx-0600
| Article | Year |
|---|---|
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome.
Topics: Biomarkers; Gastrointestinal Agents; Glucagon-Like Peptide 2; Humans; Intestine, Small; Mannitol; Short Bowel Syndrome | 2023 |